Clinical Trial Update: A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical study is evaluating hetrombopag for preventing chemotherapy-induced thrombocytopenia in nasopharyngeal carcinoma patients treated with gemcit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Thrombocytopenia
• Nasopharyngeal Carcinoma

Drugs mentioned

• Hetrombopag (hetrombopag)

Snippet

Sponsor: Fujian Cancer Hospital | Conditions: Nasopharyngeal Carcinoma (NPC), CTIT-Chemotherapy Induced Thrombocytopenia | Phase 2 | Status: NOT_YET_RECRUITING